Letters to the editors

Melanoma Research

Volumn 12, Issue 6, 2002, Pages 633-

  Guidi, B ^a   Diociaiuti, A ^a   Capizzi, R ^a   Forni, F ^a   Scribano, D ^a   Vultaggio, P ^a   Zappacosta, B ^a   Amerio, P L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100; BIOLOGICAL MARKER;

CANCER RISK; CLINICAL ARTICLE; DERMATITIS; DISEASE MARKER; FOLLOW UP; HUMAN; IMMUNOASSAY; KIDNEY DISEASE; LABORATORY DIAGNOSIS; LETTER; LUMINESCENCE; MELANOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; SERUM; SKIN INFLAMMATION; STROKE; TUMOR GROWTH; BLOOD; NOTE; SKIN TUMOR;

BIOLOGICAL MARKERS; DERMATITIS; HUMANS; MELANOMA; PSORIASIS; S100 PROTEINS; SKIN NEOPLASMS;

EID: 0036939965     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200212000-00014     Document Type: Letter

References (7)

1. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF hand type with intracellular and extra cellular functional roles. Int J Biochem Cell Biol 2001; 33(7): 637-668.
2. Mohammed MQ, Abraha HD, Sherwood RA, MacRae K, Retsas SO. Serum S100beta protein as a marker of disease activity in patients with malignant melanoma. Med Oncol 2001; 18(2): 109-112.
3. Meral R, Duranyildiz D, Las F, Camlica H, Yasasever V, Kurul S, et al. Prognostic significance of melanoma inhibiting activity levels in malignant melanoma. Melanoma Res 2001; 11(6): 627-632.
4. Krahn G, Kaskel P, Sander S, Waizenhofer PJ, Wortmann S, Leiter U, Peter RU. S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase. Anticancer Res 2001; 21(2B): 1311-1316.
5. Lara DR, Gama CS, Belmonte-de-Abreu P, Portela LV, Goncalves CA, Fonseca M, et al. Increased serum S100B protein in schizophrenia: A study in medication-free patients. J Psychiatr Res 2001; 35(1): 11-14.
6. Kuzumi E, Vuylsteke A, Guo X, Menon DK. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2000; 85(6): 936-937.
7. Wagner V, Rudi J, Naher H, Stremmel W. Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas. Med Oncol 2000; 17(1): 35-38.